Phase I Clinical Study with Pharmacokinetic Analysis of 2-0-D-Ribofuranosylthiazole-4-carboxamide (NSC 286193) Administered as a Five-Day Infusion

Donald L. Trump, Kendra D. Tutsch, Jim M. Koeller, Douglass C. Tormey

    Research output: Contribution to journalArticlepeer-review

    29 Scopus citations

    Fingerprint

    Dive into the research topics of 'Phase I Clinical Study with Pharmacokinetic Analysis of 2-0-D-Ribofuranosylthiazole-4-carboxamide (NSC 286193) Administered as a Five-Day Infusion'. Together they form a unique fingerprint.

    Medicine & Life Sciences